(0.25; 0.5; 1 and 5 mglrat; 5 r a t s l d o s e ) were determined i n hypophysectomized female r a t s , submitted f o r 7 days t o a normal (15 %; n = 25) o r a low p r o t e i n d i e t (5 %; n = 25). Binding s t u d i e s were performed with 1251-bovine GH. The l i v e r GH binding c a p a c i t i e s (pmollmg DNA; mean 5 SE) of t h e low protein-fed r a t s (0.85 + 0.07) were not s i g n i f i c a n t l y d i f f e r e n t (P > 0.05) from those of normal protein-fed animals (1.09 + 0.16). Also, the a f f i n i t y constants were not a f f e c t e d by p r o t e i n intake. Basal serum Sm-C l e v e l s , determined by RIA, were s i m i l a r i n both groups and increased i n a dose-dependent manner i n response t o GH. However f o r each GH dose, t h e Sm-C response i n t h e low protein-fed r a t s was lower. The maximal Sm-C response t o GH (5 mg) was i n t h e malnourished r a t s (0.13 + 0.04 Ulml) s i g n i f ic a n t l y reduced when compared t o t h e c o n t r o i s (0.36 + 0.03 U/ml; P C 0.001).
p o s s i b l e r o l e f o r a postreceptor defect has not been evaluated. To address t h i s question, t h e l i v e r GH binding s i t e s and t h e serum Sm-C responses t o s i n g l e i n j e c t i o n s of s a l i n e o r bovine GH (0.25; 0.5; 1 and 5 mglrat; 5 r a t s l d o s e ) were determined i n hypophysectomized female r a t s , submitted f o r 7 days t o a normal (15 %; n = 25) o r a low p r o t e i n d i e t (5 %; n = 25). Binding s t u d i e s were performed with 1251-bovine GH. The l i v e r GH binding c a p a c i t i e s (pmollmg DNA; mean 5 SE) of t h e low protein-fed r a t s (0.85 + 0.07) were not s i g n i f i c a n t l y d i f f e r e n t (P > 0.05) from those of normal protein-fed animals (1.09 + 0.16). Also, the a f f i n i t y constants were not a f f e c t e d by p r o t e i n intake. Basal serum Sm-C l e v e l s , determined by RIA, were s i m i l a r i n both groups and increased i n a dose-dependent manner i n response t o GH. However f o r each GH dose, t h e Sm-C response i n t h e low protein-fed r a t s was lower. The maximal Sm-C response t o GH (5 mg) was i n t h e malnourished r a t s (0.13 + 0.04 Ulml) s i g n i f ic a n t l y reduced when compared t o t h e c o n t r o i s (0.36 + 0.03 U/ml; P C 0.001).
I n conclusion, the blunted maximal Sm-C response t o GH tog e t h e r with unaltered l i v e r GH binding suggest t h a t p r o t e i n m a l n u t r i t i o n induces a GH postreceptor d e f e c t .
E.A.Werder, R . I l l i g , M.Zachmann, T.Torresani,
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TREATMENT OF PRECOCIOUS PUBERTY IN GIRLS WITH INTRANASAL LHRH AGONIST (BUSERELIN)
Ten g i r l s with idiopathic precocious puberty were t r e a t e d f o r 1 -3 years with Buserelin (B) i n t r a n a s a l l y a t a d a i l y dose of 200 -900 ug. The d a t a a r e compared t o those obtained previously in 21 untreated and in 13 g i r l s with precocious puberty t r e a t e d with cyproterone a c e t a t e (Pediat Res 8.248-256.1974 ). B was c l i n i c a l l y e f f e c t i v e in suppressing menses in a l l but one g i r l who had low gonadotropins a t o n s e t . Breast s i z e did not increase in 8 . but pubic and a x i l l a r y h a i r develo~ment progressed in 8 p a t i e n t s . Peak LH (179.3 -39.5 vs 99.1 -24.9 u g l l ) and FSH (451 ' 73.4 vs 164.8 -29.1 u g l l ) a f t e r LHRH were markedly suppressed during t h e f i r s t months of treatment and remained low t h e r e a f t e r . Basal LH increased i n t i a l l y (18.6 -3.8 vs 71.1 ' 17.0 u g l l ) and p e r s i s t e n t l y while basal FSH remain unchanged. P r l . El. E2 l e v e l s were unaffected. DHEA gradually increased a s seen in normal g i r l s . Differences in height SDS a t t h e beginning (1 -72 ' 0.44). a t 1 y r (2.01 ' 0.43) and a t 2 years of treatment (1.95 h . 5 3 ) were yinimal a s were corresponding SDS f o r bone age (3.27 h . 5 3 ; 4.15 -0.54; 4.19 ' 0.53) and f o r height prediction r e l a t e d t o t a r g e t height (-1.20 ' 0.61; -1.40 ' 0.48; -173 -0.39). The data of s t a t u r a l and s k e l e t a l development of B-treated g i r l s a r e not s i g n i f i c a n t l y d i f f e r e n t from those of untreated g i r l s nor from those t r e a t e d with cyproterone a c e t a t e . Supported by Swiss National Science Foundation g r a n t 3.406.083. Cloned human X chromosome fragments i d e n t i f y i n g DNA sequence polymorphisms have been used a s genetic markers i n linkage s t u d k s t o l o c a l i s e t h e abnormal gene t h a t causes X-linked hypophosphataemic r i c k e t s . These linkage s t u d i e s were performed i n 1 1 f a m i l i e s i n which t h e disease had occured i n 3 o r more genera t i o n s . Leucocyte DNA was extracted and digested with r e s t r i c t i o n endonucleases ( P s t I , Pvu 11, EcoRI o r Taq I ) , electrophoresed on 0.8% agarose g e l s , t r a n s f e r r e d t o Hybond-N membranes and hybridised with an appropriate X chromosome radioactive probe: 782, 754, D2, 99.6 and L128 f o r t h e s h o r t arm and 52A, DXYSl and S9 f o r t h e long arm. Lod scores f o r linkage between t h e r e s t r i c t i o n fragment length polymorphism (RFLP) and t h e disease were calculated using t h e MLINK computer program and t h e order of gene l o c i determined with LINKMAP. Linkage was established between hypophosphataemic r i c k e t s and an RFLP f o r probe 99.6 (peak lod score = 4 . 8 , 8 = 0.10) and a d i s t a l position within 10 centimorgans of t h e 99.6 locus is favoured. T h i s l o c a l i s e s t h e hypophosphataemic r i c k e t s gene t o t h e region Xp22.31 -Xp21.3.
Thus t h e gene regulating phosphate excretion is mapped t o t h e short arm of t h e X chromosome. Defining t h e gene locus may srovide g e n e t i c markers f o r e a r l i e r diagnosis and f u r t h e r e l u c i d a t e t h e biochemical defect. I n s u l i n s t i m u l a t e s i n t r a c e l l u l a r carbohydrate p r o t e i n and lip i d metabolism, whereas i n s u l i n -l i k e growth f a c t o r I (IGF I ) promotes c e l l d i v i s i o n . We r e c e n t l y demonstrated t h a t human B u r k i t t type ALL c e l l s i n longterm c u l t u r e displayed high a f f i n i t y binding f o r i n s u l i n and IGF I. This r a p i d l y p r o l i f e r a t i n g c e l l l i n e expresses l a r g e numbers of receptor binding s i t e s both for insul i n and IGF I. C e l l cycle s p e c i f i c separation was performed by counterflow cent r i f u g a t i o n . C e l l s were analyzed by flowcytometry. Receptor binding was determined by Scatchard a n a l y s i s . C e l l s could be enr i c h e d t o 60430% p u r i t y f o r GI-S-G2 phase. The i n s u l i n receptor displayed 10-15000 r e c e p t o r s i t e s / c e l l i n GI-, 1000-5000 i n Sand 40-50000 i n G2-phase. The a f f i n i t y of i n s u l i n binding decreased continously during c e l l cycle. The IGF I receptor displayed 2000 r e c e p t o r s i t e s / c e l l i n GI-, 5000 i n S-and 15000 i n G2-phase The a f f i n i t y of t h e IGF I receptor was high i n GI-phase showing a sharp decrease towards S-phase followed by a s l i g h t increase towards G2-phase. IGF I shows high a f f i n i t y binding during G 1 i n B u r k i t t type ALL c e l l s . This suggests t h a t IGF I is important f o r i n i t i a t i o n of p r o l i f e r a t i o n . The outstanding reduction i n i n s u l i n receptor binding s i t e s during S-phase i n d i c a t e s r e f r a c t o r i n e s s of t h e c e l l t o t h e metabolic a c t i o n of i n s u l i n during DNA r e p l i c a t i o n .
Lyon, France. LONG TERM FOLLOW-UP OF LHRH-A TREATMENT OF PRECOCIOUS PUBERTY BY URINARY GONADOTROPINS (UG) : ESCAPE OF FSH DESENSITIZATION IN GIRLS
The amounts of gonadotrophins in 24 h urines (U-LH, U-FSH) reflect spontaneous gonadotrophin secretion and should be taken as a good marker of the onset of puberty. Thirteen cases of precocious puberty (10 girls and 3 boys) have been treated with monthly IM injections of a long acting D-TRP-6 LHRH (DECAPEPTYL). 24 h urines are collected on days 15 and 30 following each injection. In every case, the efficiency of treatment was certified by the decrease of clinical manifestations, growth velocity, uterine size, plasma levels of testosterone and with no response to LHRH test (J. Clin. Endocrinol. Metab., 1986,4, 670) . In both sexes, after a short rise, U-LH rapidly fall to prepubertal levels and remained unchanged thereafter. In girls, U-FSH decreased dramatically during the first month (p < 0.001), and then rose significantly (p < 0.002) during 2nd-4th month remaining in a prepubertal range.
After 5 months of treatment, an important increase of U-FSH was observed in 3 out of the 10 girls with secretion ranging stade 11 of puberty (> 2.14 IU/24 h) and a bone age > 12 yrs. In boys, this escape of U-FSH has not been observed. Our data show the usefulness of UG excretion in LHRH treatment of precocious puberty. But in bone age > 12 yrs an increase of U-FSH without any clinical relapse suggests a selective escape of desensitization of FSH which could be taken as an index of hypothalamo-pituitary maturation and therapeutic interruption. WITEI A GnRB AGONIST Daily treatment with a GnRH agonist (GnRH-A) r a p i d l y i n h i b i t s r e p r o d u c t i v e f u n c t i o n s . 1 n o r d e r t o e v a l u a t e t h e r e l a t i v e importance of d e s e n s i t i z a t i o n a t t h e p i t u i t a r y and t h e g o n a d a l l e v e l s , immature male r a t s were t r e a t e d d a i l y with t h e GnRH-A user el in^ ( 5 ug/d i n o i l ) s t a r t i n g a t 40 days of l i f e . After 1 day t r e a t m e n t , t e s t i c u l a r c o n t e n t o f L H r e c e p t o r s a n d r e s p o n s i v e n e s s t o LH s t i m u l a t i o n w e r e a l r e a d y m a r k e d l y depressed. After 4 days of t r e a t m e n t , i n h i b i t i o n o f t e s t i c u l a r f u n c t i o n s w a s complete, whereas each p i t u i t a r y parameter t e s t e d w a s a f f e c t e d b u t n o t c o m p l e t e l y i n h i b i t e d : p l a s m a FSH w a s s i g n i f i c a n t l y d e c r e a s e d and GnRH r e c e p t o r c o n t e n t reduced by 50%. LH response t o GnRH was blunted b u t not a b o l i s h e d . A f t e r 8 d a y s of t r e a t m e n t , a l l e n d o c r i n e f u n c t i o n s were e x t e n s i v e l y impaired. P i t u i t a r y LH c o n t e n t dropped t o v a l u e s below 5% o f t h o s e of c o n t r o l r a t s . I n c o n c l u s i o n , it appears t h a t chronic GnRH-A treatment i s very e f f e c t i v e t o a r r e s t s e x u a l m a t u r a t i o n i n t h e m a l e r a t a n d t h a t L e y d i g c e l l f u n c t i o n s a r e f i r s t a f f e c t e d . P i t u i t a r y d e s e n s i t i z a t i o n w a s c h a r a c t e r i z e d by a p o s t GnRH r e c e p t o r d e f e c t of t h e LH r e l e a s e process and impairment of LH biosynthesis. Thus, i n h i b i t i o n of sexual f u n c t i o n s by GnRH-A i n c l u d e s two s i t e s of a c t i o n i n t h e male r a t , a s i t u a t i o n which may not be analogous t o t h a t of man f o r which d e s e n s i t i z a t i o n of t e s t i c u l a r functions appears t o be l e s s important.
